Published in Am J Hum Genet on January 29, 2015
Gene Modifiers of Cystic Fibrosis Lung Disease | NCT00037765
Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis. Nat Commun (2015) 1.01
Genetic pathways explored for role in cystic fibrosis. Am J Med Genet A (2015) 0.75
Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet (2006) 115.71
Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science (2007) 23.38
Genetics of gene expression and its effect on disease. Nature (2008) 21.35
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet (2010) 10.75
Mapping complex disease traits with global gene expression. Nat Rev Genet (2009) 7.44
Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature (2013) 6.57
Candidate causal regulatory effects by integration of expression QTLs with complex trait genetic associations. PLoS Genet (2010) 4.95
The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics (2012) 4.48
Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics (2012) 4.28
Significance analysis of functional categories in gene expression studies: a structured permutation approach. Bioinformatics (2005) 4.27
Evaluation of genetic variation contributing to differences in gene expression between populations. Am J Hum Genet (2008) 4.01
Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nat Genet (2011) 3.02
X:Map: annotation and visualization of genome structure for Affymetrix exon array analysis. Nucleic Acids Res (2007) 2.69
Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Nat Genet (2012) 2.14
Heritability and genomics of gene expression in peripheral blood. Nat Genet (2014) 2.00
Regulation and function of miRNA-21 in health and disease. RNA Biol (2011) 1.99
Major histocompatibility complex genomics and human disease. Annu Rev Genomics Hum Genet (2013) 1.75
A cross-platform analysis of 14,177 expression quantitative trait loci derived from lymphoblastoid cell lines. Genome Res (2013) 1.72
Normal function of the cystic fibrosis conductance regulator protein can be associated with homozygous (Delta)F508 mutation. Pediatr Res (2002) 1.61
Meta-analysis of genome-wide association studies identifies ten loci influencing allergic sensitization. Nat Genet (2013) 1.54
Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalization. Genome Res (2013) 1.34
Gene expression changes with age in skin, adipose tissue, blood and brain. Genome Biol (2013) 1.34
Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis. Nat Genet (2012) 1.26
Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities. Hum Genet (2013) 1.10
Using the gene ontology to scan multilevel gene sets for associations in genome wide association studies. Genet Epidemiol (2011) 1.06
A yeast phenomic model for the gene interaction network modulating CFTR-ΔF508 protein biogenesis. Genome Med (2012) 1.06
Pulmonary disease severity in men with deltaF508 cystic fibrosis and residual chloride secretion. Lancet (1999) 1.05
Cigarette smoking decreases global microRNA expression in human alveolar macrophages. PLoS One (2012) 1.03
A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis genetic modifier studies. Pediatr Pulmonol (2011) 1.00
Control of cystic fibrosis transmembrane conductance regulator membrane trafficking: not just from the endoplasmic reticulum to the Golgi. FEBS J (2013) 0.96
Association of Parkinson disease with structural and regulatory variants in the HLA region. Am J Hum Genet (2013) 0.96
A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. Hum Mol Genet (2013) 0.95
Atypical activation of the unfolded protein response in cystic fibrosis airway cells contributes to p38 MAPK-mediated innate immune responses. J Immunol (2012) 0.94
GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region. Genes Immun (2014) 0.94
The neural crest-enriched microRNA miR-452 regulates epithelial-mesenchymal signaling in the first pharyngeal arch. Development (2010) 0.94
HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism. Hum Mol Genet (2013) 0.93
Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis. J Pediatr (2012) 0.93
HLA class II polymorphism in cystic fibrosis. A possible modifier of pulmonary phenotype. Am J Respir Crit Care Med (1999) 0.91
The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis. Int Immunol (2006) 0.90
Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis. Proc Am Thorac Soc (2012) 0.89
Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease. Pediatr Pulmonol (2010) 0.87
Comparing the differential effects of LPA on the barrier function of human pulmonary endothelial cells. Microvasc Res (2012) 0.86
Gene expression in whole lung and pulmonary macrophages reflects the dynamic pathology associated with airway surface dehydration. BMC Genomics (2014) 0.86
Reduced microtubule acetylation in cystic fibrosis epithelial cells. Am J Physiol Lung Cell Mol Physiol (2013) 0.83
HLA-DRB1 and HLA-DQB1 genes on susceptibility to and protection from allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Microbiol Immunol (2013) 0.83